GI side effects (mild nausea, bloating, constipation) are common as your body adjusts
Share: The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight
Even though these medications share the same active ingredient, they have different formulations, manufacturing processes, and approved indications, which affect pricing
Many users describe a heavy, full feeling after meals, even small ones
Long-acting preparations also include semaglutide (SMG), dulaglutide (DUL), long-acting release formulation of exenatide (EX-LAR), and polyethylene glycol loxenatide (PEX-168), which generally need to be injected once a week
Interestingly, Ozempic has also been proposed as a potential treatment for addiction due to its ability to regulate reward pathways in the brain, which are activated by substance use